Results 161 to 170 of about 131,422 (339)
Oral microbiota and central nervous system diseases: A review
Oral microbiota is the second largest microbial colony in the body and forms a complex ecological community that influences oral and brain health. Impaired homeostasis of the oral microbiota can lead to pathological changes, resulting in central nervous ...
Xiaoxuan Zhang+7 more
doaj +1 more source
Theoretical Aspects of Neuroprotection in Acute Ischaemic Stroke. I: Basic Mechanisms
Michelle Davis, D H Barer
openalex +1 more source
Abstract Background The endocannabinoid system is a neuromodulatory system implicated in cellular processes during both development and regeneration. The Mexican axolotl, one of only a few vertebrates capable of central nervous system regeneration, was used to examine the role of the endocannabinoid system in the regeneration of the tail and spinal ...
Michael Tolentino+3 more
wiley +1 more source
Somsri Wiwanitkit, Viroj Wiwanitkit
openaire +3 more sources
Abstract Background Alternating Hemiplegia of Childhood (AHC) is a severe channelopathy that manifests before 18 months of age, primarily caused by pathogenic variants in the ATP1A3 gene. It is characterized by recurrent and disabling episodes of plegia, dystonia, dysautonomia, along with chronic neurological features and cardiac arrhythmias. About 50%
Ramona Cordani+8 more
wiley +1 more source
Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System [PDF]
Ning Tong+15 more
openalex +1 more source
Potential circadian effects on translational failure for neuroprotection
E. Esposito+12 more
semanticscholar +1 more source
Abstract Patients with TUBA1A pathogenic variants may present with complex brain malformation, intellectual disability, and epilepsy. The epilepsy phenotype is varied, ranging from mild to severe, with epileptic spasms and focal seizures being the most common seizure types.
Andy Cheuk‐Him Ng+1 more
wiley +1 more source
Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R,S)‐4‐phosphonophenylglycine [PDF]
Clemens F Sabelhaus+4 more
openalex +1 more source